The National Verification System
For End Users in Belgium and Luxembourg
IS NOW LIVE
End Users must request access NOW
Version 1.01 of the National Medicines Verification System (NMVS) for end users in Belgium and Luxembourg is now Live. Marketing Authorisation Holders have started uploading data to the repository.
The Verification System is now also ready to on board the End Users from the supply chain who are called to verify and decommission packs to be compliant with the Delegated Regulation.
Following set of documents describe the different processes that are critical to a successful implementation and on boarding of End Users.
WHAT IS AN END USER ?
What is the definition of an End User?
When are different users within a same organisation to be considered as different End Users?
WHO ARE THE END USERS OF THE VERIFICATION SYSTEM?
Who is expected to be an End User according the Delegated Regulation and the decisions of the national competent authorities? What different types of End Users can be identified?
HOW CAN END USERS ON BOARD TO THE VERIFICATION SYSTEM
What are the different steps to be followed by an End Users to implement the access to the Verification system?
CONTRACTUAL ON BOARDING BY END USERS
ACCESS REQUEST VERIFICATION BY BeMVO
SUPPORTING DOCUMENTS
A set of documents and other relevant information for the implementation of FMD
- Development portal and implementation support
- End users and FMD activity
- 2D matrix and Product codes reading
- Automate User Implementation
- FMD – Falsification alerts – 20181001
- NMVS – Incidents mngt – 20181001
